Evan M Hersch

Title: Evan M Hersch: Innovator in Antibiotic Formulation

Introduction

Evan M Hersch is an accomplished inventor based in the United States. He has made significant contributions to the field of antibiotic formulations, particularly focusing on innovative methods to combat bacterial infections. His work is characterized by a commitment to developing effective treatments for both drug-susceptible and drug-resistant bacteria.

Latest Patents

Evan M Hersch holds a patent titled "Antibiotic Formulation And Use For Bacterial Infections." This patent describes a liposomal aminoglycoside formulation that includes a neutrallipid, a negatively charged lipid, and a sterol. The formulation is designed to contain unilamellar vesicles with an average size below 100 nm. Additionally, the patent outlines a process for creating liposomes containing an aminoglycoside, as well as a method for treating various bacterial infections.

Career Highlights

Evan M Hersch is currently associated with Amplimed, Inc., where he continues to advance his research in antibiotic formulations. His innovative approach has the potential to significantly impact the treatment of bacterial infections, especially in an era where antibiotic resistance is a growing concern.

Collaborations

Evan has collaborated with notable professionals in his field, including Eskild A Petersen and Richard T Proffitt. These collaborations have likely contributed to the development and refinement of his innovative formulations.

Conclusion

Evan M Hersch is a notable inventor whose work in antibiotic formulations is paving the way for new treatments against bacterial infections. His dedication to innovation in this critical area of healthcare is commendable and holds promise for future advancements.